A7544
Anti-Albumin antibody produced in goat
whole antiserum
Synonym(s):
Serum albumin antibody
Product Name
Anti-Albumin antibody produced in goat, whole antiserum
biological source
goat
conjugate
unconjugated
antibody form
whole antiserum
antibody product type
primary antibodies
clone
polyclonal
form
liquid
contains
15 mM sodium azide
species reactivity
human
technique(s)
indirect ELISA: 1:50,000
quantitative precipitin assay: 3.0
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... ALB(213)
Application
Anti-Albumin antibody produced in goat has been used in sandwich enzyme linked immunosorbent assays (ELISA), quantitative precipitin assay and immunofluorescence.
Biochem/physiol Actions
Albumin is a transport protein that binds a broad range of ligands such as fatty acids, bilirubin, hemin, drugs, amino acids and ions among several others. Albumin may also function as a zinc carrier protein and consequently regulate physiological processes.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Albumin (ALB) is an autosomal gene with 15 exons mapped to human chromosome 4q13.3. The gene codes for a circulating human albumin protein containing 585 amino acid residues and 17 disulfide bridges. It is biosynthesized in the hepatocyte.
Immunogen
purified human albumin
Physical form
Supplied as a liquid containing 15mM sodium azide as preservative.
Preparation Note
treated to remove lipoproteins
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Maja Thim Larsen et al.
Journal of controlled release : official journal of the Controlled Release Society, 287, 132-141 (2018-07-18)
Recombinant albumin-drug genetic fusions are an effective technology to prolong the serum half-life of therapeutics that has resulted in marketed products. Indirect evidence suggests albumin fusions' long circulation is controlled by engagement with the cellular recycling neonatal Fc receptor (FcRn)
Albumin as fatty acid transporter
van der Vusse GJ
Drug Metabolism and Pharmacokinetics, 24, 300-307 (2009)
A novel mutation in the albumin gene (c.1A>C) resulting in analbuminemia
Caridi G, et al.
European Journal of Clinical Investigation, 43, 72-78 (2013)
C Magnon et al.
Gene therapy, 15(21), 1436-1445 (2008-06-13)
Given as a prophylactic treatment, a single muscle electrogene transfer of plasmid coding canstatin fused to human serum albumin (CanHSA), slowed down the development of two xenografted human carcinomas from mammary (MDA-MB-231) and prostate origin (PC-3) in nude mice and
Marwa Elkhashab et al.
Molecular pharmaceutics, 21(2), 491-500 (2024-01-12)
Antisense nucleic acid drugs are susceptible to nuclease degradation, rapid renal clearance, and short circulatory half-life. In this work, we introduce a modular-based recombinant human albumin-oligonucleotide (rHA-cODN) biomolecular assembly that allows incorporation of a chemically stabilized therapeutic gapmer antisense oligonucleotide
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service